Growth Metrics

Amicus Therapeutics (FOLD) Other Working Capital Changes (2016 - 2025)

Amicus Therapeutics filings provide 16 years of Other Working Capital Changes readings, the most recent being $595000.0 for Q4 2025.

  • On a quarterly basis, Other Working Capital Changes fell 95.83% to $595000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.4 million, a 109.9% increase, with the full-year FY2025 number at $1.4 million, up 109.9% from a year prior.
  • Other Working Capital Changes hit $595000.0 in Q4 2025 for Amicus Therapeutics, up from -$7.6 million in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $15.0 million in Q4 2021 to a low of -$19.3 million in Q2 2024.
  • Median Other Working Capital Changes over the past 5 years was $856500.0 (2022), compared with a mean of $379800.0.
  • The widest YoY moves for Other Working Capital Changes: up 1147.46% in 2023, down 3037.48% in 2023.
  • Amicus Therapeutics' Other Working Capital Changes stood at $15.0 million in 2021, then plummeted by 95.93% to $611000.0 in 2022, then plummeted by 3037.48% to -$17.9 million in 2023, then soared by 179.42% to $14.3 million in 2024, then tumbled by 95.83% to $595000.0 in 2025.
  • The last three reported values for Other Working Capital Changes were $595000.0 (Q4 2025), -$7.6 million (Q3 2025), and $4.8 million (Q2 2025) per Business Quant data.